Stock ownership · SEC 13F · Q3 2025

AKERO THERAPEUTICS INC

Who owns AKERO THERAPEUTICS INC (CUSIP 00973Y108)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.

$400K
Reported value
3
Institutions
100%
Top-5 share

The verdict

As of Q3 2025, 3 institutions report $400K in AKERO THERAPEUTICS INC positions, ownership that is dominated by its top few institutional owners.

3
institutions hold it
$400K
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q3 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 00973Y108 · Q3 2025 $0M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-MID · BOOK-MID

  • VALUE-TRACE $0.4M
  • HOLDERS-FOCUS 3 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-MID 3 new
  • BOOK-MID 5Q history

Read with: Ownership concentration guide - AKERO THERAPEUTICS INC's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Largest institutional holders of AKERO THERAPEUTICS INC
  1. 1
    CIBC Bancorp USA Inc. $354K
  2. 2
    JPMORGAN CHASE & CO $44K
  3. 3
    Bell Investment Advisors, Inc $2K

Top 3 reported holders by value · Q3 2025

Institutional ownership over time

The number of institutions reporting a AKERO THERAPEUTICS INC position has risen from 2 to 3 over the last 5 quarters of 13F filings.

0.511.522.533.5 Q1'24Q2'24Q1'25Q2'25Q3'25 3
Distinct 13F filers holding AKERO THERAPEUTICS INC, by quarter

Top Institutional Holders

# Institution Shares Value Share of reported
1 CIBC Bancorp USA Inc. 7,451 $354K 88.5%
2 JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) 929 $44K 11.0%
3 Bell Investment Advisors, Inc 39 $2K 0.5%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among AKERO THERAPEUTICS INC's reported holders for Q3 2025, by reported value:

Shared-defined discretion (DFND)
88.5%
Shared-other discretion (OTR)
11.0%
Sole discretion (SOLE)
0.5%

Latest Quarter Activity · Q3 2025

New positions (3)

CIBC Bancorp USA Inc. $354K
JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) $44K
Bell Investment Advisors, Inc $2K

Complete exits (3)

Squarepoint Ops LLC exited
China Universal Asset Management Co., Ltd. exited
Neuberger Berman Group LLC exited

Frequently Asked Questions

How many institutions hold AKERO THERAPEUTICS INC?▼
AKERO THERAPEUTICS INC is held by 3 institutional investors per the latest SEC Form 13F filings as of Q3 2025.
What is the total institutional value of AKERO THERAPEUTICS INC?▼
Institutions report $400K of AKERO THERAPEUTICS INC as of Q3 2025.
How concentrated is ownership of AKERO THERAPEUTICS INC?▼
The top five institutional holders account for 100% of the reported institutional value in AKERO THERAPEUTICS INC, making ownership dominated by its top few institutional owners.
Who is the largest institutional holder of AKERO THERAPEUTICS INC?▼
CIBC Bancorp USA Inc. is the largest reported holder of AKERO THERAPEUTICS INC with $354K across 7,451 shares as of Q3 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q3 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.